Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1127910

Cover Image

PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1127910

Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

PUBLISHED:
PAGES: 107 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 2499
PDF (5 User License)
USD 3499
PDF (Corporate License)
USD 4499

Add to Cart

The global wound care biologics market size reached US$ 1.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2027, exhibiting a growth rate (CAGR) of 8.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.

Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global wound care biologics market report, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product, wound type, application and end-user.

Breakup by Product:

  • Biologic Skin Substitutes
  • Human Donor Tissue-Derived Products
  • Acellular Animal-Derived Products
  • Biosynthetic Products
  • Topical Agents

Breakup by Wound Type:

  • Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Pressure Ulcers
  • Others
  • Surgical and Traumatic Wounds
  • Burns

Breakup by Application:

  • Acute Wound
  • Chronic Wound
  • Surgical Wound

Breakup by End-User:

  • Hospitals
  • ASCs
  • Burn Centres and Wound Clinics

Breakup by Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Molnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group and Solsys Medical, etc.

Key Questions Answered in This Report:

  • How has the global wound care biologics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global wound care biologics industry?
  • What has been the impact of COVID-19 on the global wound care biologics industry?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the wound type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global wound care biologics industry?
  • What are the key driving factors and challenges in the global wound care biologics industry?
  • What is the structure of the global wound care biologics industry and who are the key players?
  • What is the degree of competition in the global wound care biologics industry?
Product Code: SR1022A179_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Wound Care Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by Wound Type
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product

  • 6.1 Biologic Skin Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Human Donor Tissue-Derived Products
      • 6.1.2.2 Acellular Animal-Derived Products
      • 6.1.2.3 Biosynthetic Products
    • 6.1.3 Market Forecast
  • 6.2 Topical Agents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Wound Type

  • 7.1 Ulcers
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Diabetic Foot Ulcers
      • 7.1.2.2 Venous Ulcers
      • 7.1.2.3 Pressure Ulcers
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Surgical and Traumatic Wounds
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Burns
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Acute Wound
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Chronic Wound
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Surgical Wound
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 ASCs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Burn Centres and Wound Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 Asia Pacific
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 North America
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porter's Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Smith & Nephew
    • 15.3.2 Molnlycke Health Care
    • 15.3.3 Integra lifesciences
    • 15.3.4 Osiris Therapeutics
    • 15.3.5 Avita Medical
    • 15.3.6 ConvaTec Group
    • 15.3.7 Cytori Therapeutics
    • 15.3.8 Mylan
    • 15.3.9 Johnson & Johnson
    • 15.3.10 Leap Therapeutics
    • 15.3.11 Nuo Therapeutics
    • 15.3.12 Mallinckrodt
    • 15.3.13 Wright Medical
    • 15.3.14 Mimedx Group
    • 15.3.15 Solsys Medical
Product Code: SR1022A179_Report

List of Figures

  • Figure 1: Global: Wound Care Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Wound Care Biologics Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Wound Care Biologics Market: Breakup by Product (in %), 2021
  • Figure 4: Global: Wound Care Biologics Market: Breakup by Wound Type (in %), 2021
  • Figure 5: Global: Wound Care Biologics Market: Breakup by Application (in %), 2021
  • Figure 6: Global: Wound Care Biologics Market: Breakup by End-User (in %), 2021
  • Figure 7: Global: Wound Care Biologics Market: Breakup by Region (in %), 2021
  • Figure 8: Global: Wound Care Biologics Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 9: Global: Wound Care Biologics Industry: SWOT Analysis
  • Figure 10: Global: Wound Care Biologics Industry: Value Chain Analysis
  • Figure 11: Global: Wound Care Biologics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Wound Care Biologics (Biologic Skin Substitutes) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 13: Global: Wound Care Biologics (Biologic Skin Substitutes) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 14: Global: Wound Care Biologics (Topical Agents) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 15: Global: Wound Care Biologics (Topical Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 16: Global: Wound Care Biologics (Ulcers) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 17: Global: Wound Care Biologics (Ulcers) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 18: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 19: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 20: Global: Wound Care Biologics (Burns) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 21: Global: Wound Care Biologics (Burns) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 22: Global: Wound Care Biologics (Acute Wound) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 23: Global: Wound Care Biologics (Acute Wound) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 24: Global: Wound Care Biologics (Chronic Wound) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 25: Global: Wound Care Biologics (Chronic Wound) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 26: Global: Wound Care Biologics (Surgical Wound) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 27: Global: Wound Care Biologics (Surgical Wound) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 28: Global: Wound Care Biologics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 29: Global: Wound Care Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 30: Global: Wound Care Biologics (ASCs) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 31: Global: Wound Care Biologics (ASCs) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 32: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 33: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 34: Asia Pacific: Wound Care Biologics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 35: Asia Pacific: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 36: North America: Wound Care Biologics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 37: North America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 38: Europe: Wound Care Biologics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 39: Europe: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 40: Middle East and Africa: Wound Care Biologics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 41: Middle East and Africa: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 42: Latin America: Wound Care Biologics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 43: Latin America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

  • Table 1: Global: Wound Care Biologics Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Wound Care Biologics Market Forecast: Breakup by Product (in Million US$), 2022-2027
  • Table 3: Global: Wound Care Biologics Market Forecast: Breakup by Wound Type (in Million US$), 2022-2027
  • Table 4: Global: Wound Care Biologics Market Forecast: Breakup by Application (in Million US$), 2022-2027
  • Table 5: Global: Wound Care Biologics Market Forecast: Breakup by End-User (in Million US$), 2022-2027
  • Table 6: Global: Wound Care Biologics Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 7: Global: Wound Care Biologics Market Structure
  • Table 8: Global: Wound Care Biologics Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!